A new review has found that 24.7% of children with Down syndrome have abnormal head posture. Medscape Medical News
Category: News
Lab Notes: Knockout Mice May Be Autism Model
(MedPage Today) — Mice lacking a gene related to neural development showed behavioral abnormalities strongly reminiscent of autism, potentially shedding light on mechanisms and potential treatments. Also in this week’s Lab Notes, a potential strategy …
Glassesof: App to Combat Presbyopia
It might seem a bit odd: an iPhone application to improve the ability people with presbyopia to see up close. But next year Ucansi, a U.S. company based in Israel, will launch their app called “Glassesof”.
Instead of trying to improve aging eyes, this app is developed to boost visual acuity by using a proprietary method that affects the brain’s vis (Read more...)
Loma Linda University’s Vision Intervention Program receives Spot screener from PediaVision
PediaVision today announced that Loma Linda University’s Vision Intervention Program is the first in the State of California to receive the revolutionary new vision screener from PediaVision called “Spot.”
Many Canadians are not screening for glaucoma earlier, finds study
Glaucoma is the second leading cause of blindness worldwide. Although it can be treated, new research shows Canadians may not be doing enough to protect themselves. According to a new study by Lawson Health Research Institute’s Dr. Cindy Hutnik, many C…
‘Pink Eye’ Epidemic Has Potential Treatment
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) – sometimes called “pink eye” – a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Th…
DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company’s two ongoing stem cell clinical trials in the United States authorized …
A 65-Year-Old Man With a Chronic Red Eye
A 65-year-old man presents with a chronic red eye that has not improved with treatment. What is your diagnosis? Medscape Ophthalmology
Optimal Algorithm Developed For Determining Focus Error In Eyes And Cameras
University of Texas at Austin researchers have discovered how to extract and use information in an individual image to determine how far objects are from the focus distance, a feat only accomplished by human and animal visual systems until now. Like a …
When Cellulitis Doesn’t Resolve: A Mysterious Case
Paul G. Auwaerter, MD, describes a case of facial cellulitis that would not get better and the observation that finally solved the mystery. Medscape Infectious Diseases
A Girl With a Brow Mass
What condition do you suspect is present in this 3-year-old girl with a mass on her brow? Medscape Ophthalmology
A Treatment For One Form Of Albinism?
Individuals with oculocutaneous albinism, type 1 (OCA1) have white hair, very pale skin, and light-colored irises because they have none, or very little, of the pigment melanin in their skin, hair, and eyes. Affected individuals have impaired eyesight …
Melanoma Patients Receive Extra Months Of Disease-Free Life Following Infusing Chemotherapy Into The Liver
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year…
Embryonic stem cell therapy for incurable Stargardt eye disease
Full Story →
Extra Months Of Disease-Free Life For Melanoma Patients Delivered By New Treatment
Once melanoma of the eye (ocular or uveal melanoma) spreads to the liver, which happens frequently, no effective treatment is available and often the individuals die within two to four months on average, with only one in ten surviving for a year…
UK OK’s Embryonic Stem Cell Trial for Eye Disease
British drug regulators have granted approval to Advanced Cell Technology to conduct the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness, the firm said on Thursday. Reuters Health …
Canon CR-2 PLUS Non-mydriatic Retinal Camera Coming to U.S.
Having secured FDA clearance, Canon is now releasing its CR-2 PLUS digital non-mydriatic retinal camera to the U.S. market. The main feature of the camera over the CR-2 model is its ability to do fundus autofluorescence photography that is used to detect macular residue such as lipofuscin that gathers in the retinal pigment epithelial layer.
Like s (Read more...)
New Twist Uncovered In A Blindness-Causing Disease Gene
After more than three decades of research, University of Pennsylvania veterinarians and vision-research scientists, with associates at Cornell University, have identified a gene responsible for a blindness-inducing disease that afflicts dogs. In the pr…
STAAR’s new Visian ICL with CentraFLOW technology showcased at ESCRS congress
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the Visian Implantable Collamer Lens (ICL), and new Visian ICL with CentraFLOW technology utilizing the KS-AquaPORT, were …
First European Human Embryonic Stem Cell Trial Gets Go Ahead
The European authorities have given the go ahead for trials to treat patients with Stargardt’s Macular Dystrophy (SMD) using retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs). If successful, the trial may pave the way…